Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1, Investigatory Initiated, In-vitro Standardization of B Cell Elispot Assays

NCT01334281 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT01334281
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01334281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1, Investigatory Initiated, In-vitro Standardization of B Cell Elispot Assays
Lead sponsor
Northwestern University
Phase
Observational
Overall status
Terminated
Start date
February 29, 2008
Completion date
October 31, 2012
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

panel reactive antibody, sensitization to hla antigens, transplant sensitization